Skip to content
KYAN Therapeutics

KYAN Therapeutics

KYAN’s mission is to unlock the full potential of combination therapies.

  • About
  • Platform
  • News
  • Team
  • Partners
  • Contact

Category: Drug Development

KYAN Therapeutics Exclusively Licenses Small Molecule

September 24, 2020August 23, 2021 kyanetics

We acquired the rights to develop promising HDAC inhibitors for AI-powered cancer drug development. Read more in our press release: […]

Drug Development

Recent Posts

  • KYAN Therapeutics Announces Collaboration with Institute of Molecular and Cell Biology for Accelerated Drug Discovery and Development of Nucleic Acids
  • KYAN Therapeutics Exclusively Licenses Small Molecule
  • AI Platform Aids Treatment for Relapsed Lymphoma
  • Global Release of Powbab Liver Cleanse Detox

Categories

  • Consumer Health
  • Drug Development
  • Lymphoma
  • Nucleic Acids
  • Optim.AI Platform
Copyright © 2021. KYAN Therapeutics, Inc. All Rights Reserved.